All HHS Contracts — July 08, 2026

Deloitte’s $86.1 million firm-fixed-price BPA call for HSPD-12 identity management, awarded under full and open competition with $65M already outlaid, signals strong federal IT services moat and sustained funding for mandated programs.

ESIMPLICITY’s $80.1 million time-and-materials delivery order for T-MSIS product development, with $52.9M outlaid and multi-year visibility through 2027, shows strong execution and competitive positioning for a small woman-owned firm.

Booz Allen’s $84M one-year time-and-materials delivery order for Marketplace System Integration, with $56.8M outlaid, provides strong near-term cash flow but no options beyond July 2026, pressuring re-competition risk.

Leidos Biomedical’s $77.6M cost-plus-fixed-fee delivery order from NIH NCI (options up to $139.9M) offers low execution risk but is too small for material impact on Leidos Holdings’ ~$15B revenue base.

Deloitte’s $141.7M fixed-price identity contract carries medium execution risk if HHS requirements shift or performance penalties arise, though $65M already outlaid mitigates.

Booz Allen’s $84M CMS cloud contract ends July 2026 with no options; follow-on depends on future CMS budget allocations for Marketplace IT, vulnerable to CR uncertainty.

ESIMPLICITY’s $80.1M T-MSIS award represents a significant portion of its likely revenue (~$17.8M/year), creating high client concentration risk with CMS as single customer.

Booz Allen’s one-year CMS cloud contract faces immediate re-compete risk; competitors like Deloitte or Accenture could bid for the follow-on.

Deloitte’s $86M HSPD-12 win signals sustained HHS identity management spending, creating follow-on opportunities for Deloitte and peers in PIV card and credentialing services.

ESIMPLICITY’s $80M 8(a) award demonstrates policy-driven growth for woman-owned small businesses in health IT; similar firms may see increased CMS set-aside opportunities.

Leidos Biomedical’s $139.9M total NIH option value, if exercised, would boost near-term revenue visibility for Leidos in health R&D.

Three of four contracts—Deloitte (identity), Booz Allen (cloud Marketplace), and ESIMPLICITY (Medicaid data)—total $250M+ and point to HHS prioritizing cloud migration, identity security, and data systems modernization.

ESIMPLICITY’s $80M woman-owned 8(a) award highlights HHS’s commitment to small business contracting goals, creating growth opportunities for similar firms in niche systems integration.

{"entity"=>"Deloitte & Touche LLP", "reason"=>"$86M HHS identity contract with medium execution risk; option years through 2028 are key catalysts.", "trigger"=>"Option exercise announcement post-2026"}

{"entity"=>"Booz Allen Hamilton Inc", "reason"=>"$84M CMS cloud contract ends July 2026; re-compete or follow-on award announcement critical.", "trigger"=>"CMS solicitation for Marketplace System Integrator follow-on"}

{"entity"=>"ESIMPLICITY INC", "reason"=>"Concentration on $80M CMS T-MSIS contract; new contract wins or modifications to scope drive investment thesis.", "trigger"=>"CMS T-MSIS program budget release or modification notice"}

{"entity"=>"Leidos Holdings Inc", "reason"=>"$139.9M NIH option value could boost health R&D revenue if exercised.", "trigger"=>"Option year exercise by August 2026"}